Covered recipient · General Payments record
MANUEL A CASTRO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$503.53
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.40 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $114.04 | 2 |
| Novo Nordisk AS | $51.58 | 3 |
| GlaxoSmithKline, LLC. | $43.30 | 2 |
| Exact Sciences Corporation | $42.59 | 2 |
| Acerta Pharma LLC | $20.46 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.00 | 1 |
| Abbott Laboratories | $19.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.43 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125145375 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.46 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105895102 | CMS |
| Exact Sciences Corporation | $20.83 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114610315 | CMS |
| Exact Sciences Corporation | $21.76 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114610320 | CMS |
| GlaxoSmithKline, LLC. | $27.34 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116321136 | CMS |
| GlaxoSmithKline, LLC. | $15.96 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116611157 | CMS |
| Lilly USA, LLC | $99.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164097 | CMS |
| Lilly USA, LLC | $14.22 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135146158 | CMS |
| Novo Nordisk Inc | $15.70 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096651070 | CMS |
| Novo Nordisk Inc | $16.27 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097706372 | CMS |
| Novo Nordisk Inc | $19.61 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097658273 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.00 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151046804 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.